ahlam1399
05-23-2015, 01:32 AM
UPDATE 1-Amgen ends partnership with AstraZeneca on inflammation drug
May 22 (Reuters) - Amgen Inc said it will terminate a collaboration with AstraZeneca Plc to develop an inflammation drug after it observed suicidal thoughts in the subjects of a trial.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4691a14d/sc/21/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=pgfAo5Jtv5A:njNEo1-MGIc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=pgfAo5Jtv5A:njNEo1-MGIc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=pgfAo5Jtv5A:njNEo1-MGIc:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=pgfAo5Jtv5A:njNEo1-MGIc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=pgfAo5Jtv5A:njNEo1-MGIc:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/pgfAo5Jtv5A
May 22 (Reuters) - Amgen Inc said it will terminate a collaboration with AstraZeneca Plc to develop an inflammation drug after it observed suicidal thoughts in the subjects of a trial.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4691a14d/sc/21/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=pgfAo5Jtv5A:njNEo1-MGIc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=pgfAo5Jtv5A:njNEo1-MGIc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=pgfAo5Jtv5A:njNEo1-MGIc:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=pgfAo5Jtv5A:njNEo1-MGIc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=pgfAo5Jtv5A:njNEo1-MGIc:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/pgfAo5Jtv5A